EchoSolv AS vs Stethee Pro 1
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your cardiology department needs to efficiently identify and prioritize patients at high risk for severe aortic stenosis from existing echocardiogram data. This tool is ideal for enhancing workflow efficiency by providing AI-powered clinical decision support and second reader support for measurement-based analysis, without requiring EMR integration.
View EchoSolv AS →Choose Stethee Pro 1 if…
Choose Stethee Pro 1 if you require a portable, AI-enabled digital stethoscope for real-time cardiac and respiratory assessment, especially in telemedicine or remote monitoring scenarios. This system allows for advanced auscultation, vital sign capture, and secure data sharing, enabling comprehensive diagnostics beyond traditional physical exams.
View Stethee Pro 1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | Stethee Pro 1 |
|---|---|---|
| Pricing | Unknown | $499 usd |
| Deployment | Cloud-based | Cloud, Mobile |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS (Tool A) is designed to integrate seamlessly into existing PACS workflows without requiring EMR integration or new hardware, offering ultra-fast risk detection. Stethee Pro 1 (Tool B), while fast, introduces a new physical device and mobile application, which can add steps and complexity to a clinician's workflow.
Clinical Value
EchoSolv ASEchoSolv AS (Tool A) provides highly accurate, FDA-cleared clinical decision support specifically for severe aortic stenosis, a critical condition, and offers 'second reader support' to prioritize studies. Stethee Pro 1 (Tool B) offers broader real-time cardiac and respiratory vital sign analysis, but Tool A's focused, high-accuracy decision support for a specific, high-impact diagnosis suggests a more direct and potentially higher clinical impact in its niche.
Pricing & Value
Stethee Pro 1Stethee Pro 1 (Tool B) offers transparent pricing for its device ($499) and clearly states a subscription model for its AI-driven web portal. EchoSolv AS (Tool A) does not provide public pricing information, which is common for enterprise healthcare solutions but makes direct value comparison difficult without engaging the vendor.
Enterprise Readiness
EchoSolv ASBoth tools are FDA-cleared, HIPAA compliant, and cloud-based. However, EchoSolv AS (Tool A) explicitly states it integrates with PACS and requires no EMR integration, suggesting a more streamlined deployment into existing hospital IT infrastructure. Stethee Pro 1 (Tool B)'s reliance on a physical device and mobile app, while flexible, could introduce more logistical challenges for large-scale enterprise deployment and management.
Innovation
Stethee Pro 1Stethee Pro 1 (Tool B) is described as 'The World's First AI-Enabled Wireless Stethoscope System' and innovatively combines a traditional medical device with advanced AI, real-time visualization, and environmental data tagging. While EchoSolv AS (Tool A) offers innovative AI for sAS detection, Tool B's re-imagining of a fundamental diagnostic tool represents a more broadly disruptive innovation.
Support & Docs
Stethee Pro 1M3DICINE's website for Stethee Pro 1 (Tool B) appears to offer more readily available support resources, including user manuals and quick start guides, directly linked from its product pages. While Echo IQ (Tool A) likely provides support, explicit documentation or a dedicated support portal is not as immediately apparent from a quick search.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | Stethee Pro 1 |
|---|---|---|
| Name | EchoSolv AS | Stethee Pro 1 |
| Company | Echo IQ | M3DICINE Pty Ltd. |
| Primary Use Case | AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis. | AI-enabled wireless digital stethoscope system providing real-time cardiac and respiratory vital sign analysis for enhanced diagnostics and telemedicine. |
| Key AI Functionality | AI-powered clinical decision support for severe aortic stenosis probability; measurement-based AI (analyzes numerical measurements, not images); ultra-fast risk detection (under 3 seconds). | AI-enabled wireless digital stethoscope system; captures cardiac and respiratory vital signs in 20 seconds; measures systole, diastole, heart cycle durations, and respiration rate; real-time visualization of heart and lung sounds. |
| Target Medical Specialties | Cardiology, Cardiothoracic Surgery | Cardiology, Emergency Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and Stethee Pro 1.